Novavax’s (NVAX) Q3 Loss Widens, Revenues Lag Estimates Posted byZacks Equity Research November 5, 2021 Leave a comment on Novavax’s (NVAX) Q3 Loss Widens, Revenues Lag Estimates Novavax (NVAX) reports wider-than-expected loss for the third quarter of 2021 while revenues miss estimates. Shares down.